Vanguard Capital Management
TAK icon

Vanguard Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Vanguard Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Hold
123,374
– – ﹤0.01% 3428
2026
Q1 		$2.28M Buy
+123,374
New +$2.17M ﹤0.01% 3317

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Capital Management's TAK Position: Q2 2026 in Review

Vanguard Capital Management held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 123,374 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #3428.

Vanguard Capital Management first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.28M in Q1 2026. 373 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Vanguard Capital Management held 123,374 shares of Takeda Pharmaceutical worth $1.98M as of Q2 2026.
  • Vanguard Capital Management left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3428 holding.
  • Vanguard Capital Management first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Takeda Pharmaceutical position peaked at $2.28M in Q1 2026.
  • 373 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.